Project Farma, PerkinElmer’s life sciences consulting business, has partnered with Oracle Primavera Cloud (OPC) to expand its project controls and capital programme management capabilities for pharmaceutical and biotechnology organisations.
The collaboration combines Oracle’s cloud-based project management platform with Project Farma’s specialist expertise in life sciences capital delivery, creating an integrated service designed to help organisations manage increasingly complex facility development programmes.
The move comes as pharmaceutical and biotech companies continue to invest heavily in new manufacturing capacity, advanced therapy facilities and research infrastructure. However, growing project complexity, regulatory oversight and compressed delivery timelines are placing greater pressure on project controls teams to provide accurate forecasting, scheduling and programme visibility.
Project Farma said the partnership enhances its Project Controls and Project Management Information System (PMIS) offering, providing clients with both the technology platform and specialist consulting expertise needed to oversee major capital investments.
The company brings significant industry experience to the partnership, having supported more than 100 facility builds and managed over $6 billion in capital investments across the life sciences sector. This experience has shaped a project controls practice specifically focused on the unique planning, scheduling and compliance requirements associated with pharmaceutical manufacturing programmes.
According to Project Farma, many organisations continue to rely on legacy scheduling and reporting tools that struggle to cope with the scale and complexity of modern life sciences projects, particularly large-scale manufacturing facilities where construction, equipment installation, qualification and regulatory readiness activities must be carefully coordinated.
“Pharma capital programs are getting more complex faster than most project controls teams can adapt,” said Adam Barlow, Senior Vice President of Project Controls at Project Farma. “We have seen clients managing $500 million-plus facility builds with scheduling tools that were never designed for the pace, interdependencies and reporting requirements of life sciences projects.”
The partnership will allow clients to access Oracle Primavera Cloud through a fully managed service model rather than developing and maintaining project management capabilities internally. This approach is intended to accelerate implementation while providing access to dedicated project controls specialists familiar with pharmaceutical delivery requirements.
For project leaders, the integration offers enhanced visibility across capital programmes, enabling teams to monitor schedules, manage risks, track performance and coordinate stakeholders through a centralised platform. Improved project controls are becoming increasingly important as pharmaceutical companies seek to minimise delays that can impact manufacturing readiness and product launch timelines.
The collaboration also reflects a broader trend across the project delivery sector, where organisations are increasingly combining specialist consultancy expertise with enterprise project management technologies to improve governance and programme performance.
Glen Colaco, Senior Director of Project Controls and PMIS at Project Farma, said the objective is to provide pharmaceutical organisations with dedicated project environments that support stronger governance and project execution.
“Our goal is simple: give pharmaceutical capital programs a fully independent, dedicated Oracle OPC environment so their project data stays protected, their controls remain clean, and their facilities are delivered on time and inspection-ready,” he said.
As investment in biologics, cell and gene therapies, and advanced manufacturing technologies continues to grow, effective project controls are becoming a critical success factor for organisations seeking to bring new facilities online efficiently and maintain regulatory compliance.
The partnership positions Project Farma to support clients throughout the full capital project lifecycle, from programme planning and PMIS implementation through to project controls management and ongoing programme delivery support.
For life sciences organisations managing large-scale capital programmes, the combination of industry-specific project expertise and enterprise-grade project management technology could help address one of the sector’s biggest challenges: delivering increasingly complex facilities on schedule while maintaining the quality and compliance standards required for regulated manufacturing environments.
